- Home
- LOVE vs PHAR Comparison
LOVE vs PHAR Comparison
Compare LOVE & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- PHAR
- Stock Information
- Founded
- LOVE 1998
- PHAR 1988
- Country
- LOVE United States
- PHAR Netherlands
- Employees
- LOVE N/A
- PHAR N/A
- Industry
- LOVE Other Specialty Stores
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- LOVE Consumer Discretionary
- PHAR Health Care
- Exchange
- LOVE Nasdaq
- PHAR Nasdaq
- Market Cap
- LOVE 298.3M
- PHAR 731.1M
- IPO Year
- LOVE 2018
- PHAR N/A
- Fundamental
- Price
- LOVE $18.11
- PHAR $10.00
- Analyst Decision
- LOVE Strong Buy
- PHAR Strong Buy
- Analyst Count
- LOVE 5
- PHAR 3
- Target Price
- LOVE $30.40
- PHAR $30.00
- AVG Volume (30 Days)
- LOVE 407.2K
- PHAR 3.6K
- Earning Date
- LOVE 06-12-2025
- PHAR 07-31-2025
- Dividend Yield
- LOVE N/A
- PHAR N/A
- EPS Growth
- LOVE N/A
- PHAR N/A
- EPS
- LOVE 0.82
- PHAR N/A
- Revenue
- LOVE $686,358,000.00
- PHAR $320,708,000.00
- Revenue This Year
- LOVE $6.56
- PHAR $13.31
- Revenue Next Year
- LOVE $7.23
- PHAR $7.68
- P/E Ratio
- LOVE $21.98
- PHAR N/A
- Revenue Growth
- LOVE N/A
- PHAR 24.13
- 52 Week Low
- LOVE $12.12
- PHAR $6.65
- 52 Week High
- LOVE $39.49
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- LOVE 44.31
- PHAR 43.61
- Support Level
- LOVE $18.42
- PHAR $9.99
- Resistance Level
- LOVE $19.41
- PHAR $10.59
- Average True Range (ATR)
- LOVE 0.83
- PHAR 0.35
- MACD
- LOVE 0.03
- PHAR -0.14
- Stochastic Oscillator
- LOVE 13.56
- PHAR 7.45
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.